Compounds > pyrrolidonecarboxylic acid

pyrrolidonecarboxylic acid and Cardiac Failure

pyrrolidonecarboxylic acid has been researched along with Cardiac Failure in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bachhawat, AK; Dubey, P; Jainarayanan, AK; Yadav, S1
Berezikov, E; Bischoff, R; de Boer, RA; Domian, IJ; Gil, A; Hoes, M; Ovchinnikova, ES; Silljé, HHW; Tromp, J; van de Sluis, B; van der Harst, P; van der Meer, P; van der Pol, A; van Deursen, JM; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Vreeswijk-Baudoin, I1
Bischoff, R; de Boer, RA; Gil, A; Grote Beverborg, N; Hoendermis, ES; Schouten, EM; Silljé, HHW; Tromp, J; van der Meer, P; van der Pol, A; van Veldhuisen, DJ; Voors, AA1
Keceli, G; Lindsey, ML; Paolocci, N; Sourdon, J1
Alexander, D; Alonso, A; Boerwinkle, E; Manolio, TA; Nettleton, JA; Yu, B; Zheng, Y1

Reviews

1 review(s) available for pyrrolidonecarboxylic acid and Cardiac Failure

ArticleYear
Heart failure and the glutathione cycle: an integrated view.
    The Biochemical journal, 2020, 09-18, Volume: 477, Issue:17

    Topics: Animals; Endoplasmic Reticulum Stress; gamma-Glutamylcyclotransferase; Glutathione; Heart Failure; Humans; Oxidative Stress; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid

2020

Other Studies

4 other study(ies) available for pyrrolidonecarboxylic acid and Cardiac Failure

ArticleYear
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.
    Science translational medicine, 2017, Nov-08, Volume: 9, Issue:415

    Topics: Animals; Cardiotonic Agents; ERRalpha Estrogen-Related Receptor; Fetus; Heart Failure; Heart Function Tests; Humans; Mice, Transgenic; Myocardial Infarction; Myocardium; Oxidative Stress; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Receptors, Estrogen; Reperfusion Injury; Sequence Analysis, RNA; Stress, Mechanical; Transcription, Genetic

2017
OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction.
    Cardiovascular research, 2018, 12-01, Volume: 114, Issue:14

    Topics: Aged; Aged, 80 and over; Animals; Case-Control Studies; Disease Models, Animal; Female; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Phenotype; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Randomized Controlled Trials as Topic; Signal Transduction; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling

2018
Death of an antioxidant brings heart failure with preserved ejection fraction to life: 5-oxoproline and post-ischaemic cardio-renal dysfunction.
    Cardiovascular research, 2018, 12-01, Volume: 114, Issue:14

    Topics: Animals; Antioxidants; Disease Models, Animal; Fibrosis; Heart Failure; Kidney Diseases; Mice; Oxidative Stress; Pyrrolidonecarboxylic Acid; Stroke Volume

2018
Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study.
    Genetic epidemiology, 2013, Volume: 37, Issue:8

    Topics: Acetyltransferases; Alleles; Atherosclerosis; Black or African American; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Cohort Studies; Fatty Acids, Unsaturated; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Heart Failure; Humans; Incidence; Isoleucine; Leucine; Male; Metabolome; Metabolomics; Middle Aged; Polymorphism, Single Nucleotide; Pyrrolidonecarboxylic Acid; Risk Factors

2013